Phase III Trial in Acute Promyelocytic Leukemia Patients (APL0406)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00482833 |
Recruitment Status :
Completed
First Posted : June 5, 2007
Last Update Posted : October 12, 2022
|
Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Collaborator:
Study Alliance Leukemia (SAL) Group
Information provided by (Responsible Party):
Gruppo Italiano Malattie EMatologiche dell'Adulto
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | September 2012 |
Actual Study Completion Date : | October 17, 2019 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):